Priority Date: 19.01.11 (US 20110457158P)

GENES AND GENES COMBINATIONS PREDICTIVE OF EARLY RESPONSE OR NON RESPONSE OF SUBJECTS SUFFERING FROM INFLAMMATORY DISEASE TO CYTOKINE TARGETING DRUGS (CYTD)

  • Application ID: EP11711830
  • Status: PATENT GRANTED

Attorney

Employment test 201 - 500 employees
Company dna regimbeau
operating since 1931
Headquarter in Paris and 8 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Cabinet Regimbeau is specialized in C12. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 19.01.2011 - Priority Date (US 20110457158P)
  • 29.09.2011 - Publication A2 (WO2011117366)
  • 30.01.2013 - Publication A2 (EP2550367)
  • 22.03.2017 - Publication B1 (EP2550367)

IPC Classification